BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: A review and a point of view. World J Gastroenterol 2014; 20(43): 15943-15954 [PMID: 25473148 DOI: 10.3748/wjg.v20.i43.15943]
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/15943.htm
Number Citing Articles
1
Pascal Pineau, Eloy Ruiz, Eric Deharo, Stéphane Bertani. On hepatocellular carcinoma in South America and early-age onset of the diseaseClinics and Research in Hepatology and Gastroenterology 2019; 43(5): 522 doi: 10.1016/j.clinre.2018.10.019
2
Marianna V. Papageorge, Alison P. Woods, Susanna W.L. de Geus, Sing Chau Ng, Michael K. Paasche-Orlow, Dorry Segev, David McAneny, Kelly M. Kenzik, Teviah E. Sachs, Jennifer F. Tseng. Beyond insurance status: the impact of Medicaid expansion on the diagnosis of Hepatocellular CarcinomaHPB 2022; 24(8): 1271 doi: 10.1016/j.hpb.2021.12.020
3
Fadi Antaki, Stephanie Judd, Ziad Kanaan, Suhag M. Patel, Kirthi K. Lilley. Textbook of Gastrointestinal Oncology2019; : 573 doi: 10.1007/978-3-030-18890-0_32
4
Ying Chen, Ming Han, Akiko Matsumoto, Yewei Wang, David C. Thompson, Vasilis Vasiliou. Alcohol and CancerAdvances in Experimental Medicine and Biology 2018; 1032: 37 doi: 10.1007/978-3-319-98788-0_3
5
Su-Chen Lan, Yueh-E Lin, Shu-Ching Chen, Yu-Fang Lin, Yu-Jen Wang. Effects of Acupressure on Fatigue and Depression in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Quasi-Experimental StudyEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/496485
6
Qian-Qian Shao, Bang-Bo Zhao, Liang-Bo Dong, Hong-Tao Cao, Wei-Bin Wang. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversiesWorld Journal of Gastroenterology 2019; 25(32): 4673-4681 doi: 10.3748/wjg.v25.i32.4673
7
Perttu Sahlman, Markku Nissinen, Eero Pukkala, Martti Färkkilä. Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013International Journal of Cancer 2016; 138(11): 2616 doi: 10.1002/ijc.29995
8
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
9
Juncheng Wei, Deyu Fang. Endoplasmic Reticulum Stress Signaling and the Pathogenesis of HepatocarcinomaInternational Journal of Molecular Sciences 2021; 22(4): 1799 doi: 10.3390/ijms22041799
10
Ashakumary Lakshmikuttyamma, Abigail Kay. A worldwide yearly survey of new data in adverse drug reactionsSide Effects of Drugs Annual 2015; 37: 45 doi: 10.1016/bs.seda.2015.08.001
11
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
12
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)Experimental and Molecular Pathology 2019; 108: 156 doi: 10.1016/j.yexmp.2019.04.002
13
S Dahlberg, U Schött. Vitamin K: A potential Liver Cancer treatment wayArchives of Hepatitis Research 2017; 3(1): 049 doi: 10.17352/ahr.000017
14
Kerstin Schütte, Fathi Balbisi, Peter Malfertheiner. Prevention of Hepatocellular CarcinomaGastrointestinal Tumors 2016; 3(1): 37 doi: 10.1159/000446680
15
Murali Ganesan, Allison Eikenberry, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Role of alcohol in pathogenesis of hepatitis B virus infectionWorld Journal of Gastroenterology 2020; 26(9): 883-903 doi: 10.3748/wjg.v26.i9.883
16
Yogambigai Rajamoorthy, Niazlin Mohd Taib, Mudatsir Mudatsir, Harapan Harapan, Abram Luther Wagner, Subramaniam Munusamy, Khalid Abdul Rahim, Alias Radam. Risk behaviours related to hepatitis B virus infection among adults in Malaysia: A cross-sectional household surveyClinical Epidemiology and Global Health 2020; 8(1): 76 doi: 10.1016/j.cegh.2019.04.011
17
Luan Nguyen, Myrthe Jager, Ruby Lieshout, Petra E. de Ruiter, Mauro D. Locati, Nicolle Besselink, Bastiaan van der Roest, Roel Janssen, Sander Boymans, Jeroen de Jonge, Jan N. M. IJzermans, Michail Doukas, Monique M. A. Verstegen, Ruben van Boxtel, Luc J. W. van der Laan, Edwin Cuppen, Ewart Kuijk. Precancerous liver diseases do not cause increased mutagenesis in liver stem cellsCommunications Biology 2021; 4(1) doi: 10.1038/s42003-021-02839-y
18
Monica Leon, Joseph Varon, Salim Surani. When a liver transplant recipient goes back to alcohol abuse: Should we be more selective?World Journal of Gastroenterology 2016; 22(20): 4789-4793 doi: 10.3748/wjg.v22.i20.4789
19
Lancharat Chuncharunee, Noriyo Yamashiki, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk. Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysisBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1050-9
20
Rup Kumar Phukan, Biswa Jyoti Borkakoty, Sanjib Kumar Phukan, Kumar Bhandari, Jagdish Mahanta, Sopai Tawsik, Sangita Bhandari, Ashish Rai, Kanwar Narain. Association of processed food, synergistic effect of alcohol and HBV with Hepatocellular Carcinoma in a high incidence region of IndiaCancer Epidemiology 2018; 53: 35 doi: 10.1016/j.canep.2018.01.005
21
P. Muriel. Liver Pathophysiology2017; : 3 doi: 10.1016/B978-0-12-804274-8.00001-1
22
Elin Storjord, Jim A. Dahl, Anne Landsem, Judith K. Ludviksen, Marlene B. Karlsen, Bård O. Karlsen, Ole-L. Brekke. Lifestyle factors including diet and biochemical biomarkers in acute intermittent porphyria: Results from a case-control study in northern NorwayMolecular Genetics and Metabolism 2019; 128(3): 254 doi: 10.1016/j.ymgme.2018.12.006
23
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinomaAdvanced Drug Delivery Reviews 2022; 182: 114114 doi: 10.1016/j.addr.2022.114114
24
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in CancersPhysiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
25
Mohamed M. Makhlouf, Mohamed Abdel Mabood, Shereen A. Saleh, Sarah El Nakeep, Sara M. Abdelhakam, Marwa Rushdy, Essam M. Abd-Al Hafez, Ahmed Abbas. Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patientsThe Egyptian Journal of Internal Medicine 2017; 29(2): 40 doi: 10.4103/ejim.ejim_4_17
26
Maria Eduarda Lopes Baitello, Graciele Domitila Tenani, Rafael Fernandes Ferreira, Victor Nogueira, Marcela Augusta de Souza Pinhel, Rita de Cássia Martins Alves da Silva, Renato Ferreira da Silva, Patrícia da Silva Fucuta, Moacir Fernandes de Godoy, Dorotéia Rossi Silva Souza. VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular CarcinomaCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/9607054
27
Vinícius Barreto Garcia, Thaís Gomes de Carvalho, Luiz Henrique da Silva Gasparotto, Heloiza Fernanda Oliveira da Silva, Aurigena Antunes de Araújo, Gerlane Coelho Bernardo Guerra, Timo Schomann, Luis J. Cruz, Alan B. Chan, Raimundo Fernandes de Araújo Júnior. Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for inflammation-induced cancer imagingNanoscale Research Letters 2019; 14(1) doi: 10.1186/s11671-019-2986-y
28
Gennaro D'Amico, Ramon Bataller. Need for surveillance of hepatocellular carcinoma in patients with alcoholic cirrhosisJournal of Hepatology 2018; 69(6): 1219 doi: 10.1016/j.jhep.2018.09.027
29
Nada Assi, Marc J Gunter, Duncan C Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M Sandanger, Amaia Molinuevo, Hendriek Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth Travis, Kim Overvad, Elio Riboli, Augustin Scalbert, Mazda Jenab, Vivian Viallon, Pietro Ferrari. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohortThe American Journal of Clinical Nutrition 2018; 108(1): 117 doi: 10.1093/ajcn/nqy074
30
Daisuke Shirai, Hiroji Shinkawa, Shigekazu Takemura, Shogo Tanaka, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Norifumi Kawada, Shoji Kubo. Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver diseaseAnnals of Medicine and Surgery 2021; 68: 102644 doi: 10.1016/j.amsu.2021.102644
31
Gianni TESTINO, Sharmila FAGOONEE, Fabio CAPUTO, Rinaldo PELLICANO. The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithmPanminerva Medica 2021; 63(3) doi: 10.23736/S0031-0808.21.04272-5
32
Kim B Pedersen, Casey F Pulliam, Aarshvi Patel, Fabio Del Piero, Tatiane T N Watanabe, Umesh D Wankhade, Kartik Shankar, Chindo Hicks, Martin J Ronis. Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with CoprococcusCarcinogenesis 2019; 40(2): 349 doi: 10.1093/carcin/bgy141
33
Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosisWorld Journal of Gastroenterology 2019; 25(32): 4715-4726 doi: 10.3748/wjg.v25.i32.4715
34
Luis Calzadilla Bertot, Leon A Adams. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2019; 13(2): 179 doi: 10.1080/17474124.2019.1549989
35
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive reviewWorld Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
36
Nur Signa Aini Gumilas, Irianiwati Widodo, Neneng Ratnasari, Didik Setyo Heriyanto. Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosisNon-coding RNA Research 2022; 7(1): 34 doi: 10.1016/j.ncrna.2022.01.004
37
Elijah Ige Ohimain. Methanol contamination in traditionally fermented alcoholic beverages: the microbial dimensionSpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3303-1
38
Stefan G. Hübscher. Practical Hepatic Pathology: a Diagnostic Approach2018; : 371 doi: 10.1016/B978-0-323-42873-6.00024-X
39
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosisWorld Journal of Gastroenterology 2018; 24(13): 1440-1450 doi: 10.3748/wjg.v24.i13.1440
40
Wei Wang, Shilin-L. Tian, Hui Wang, Chun-Chun Shao, Yong-Zheng Wang, Yu-Liang Li. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma RecurrenceJAMA Network Open 2020; 3(4): e203707 doi: 10.1001/jamanetworkopen.2020.3707
41
Mohamed Mourad, Fanny Lebossé, Philippe Merle, Massimo Levrero, Teresa Antonini, Mickaël Lesurtel, Christian Ducerf, Fabien Zoulim, Jean‐Yves Mabrut, Kayvan Mohkam. External validation of the French alpha‐fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort – a retrospective studyTransplant International 2021; 34(3): 535 doi: 10.1111/tri.13819
42
Tamar Thurm, Oren Shibolet. Hepatocellular Carcinoma2016; : 409 doi: 10.1007/978-3-319-34214-6_27
43
Rolf Teschke. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical AspectsBiomedicines 2018; 6(4): 106 doi: 10.3390/biomedicines6040106
44
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver diseaseScandinavian Journal of Gastroenterology 2019; 54(6): 746 doi: 10.1080/00365521.2019.1627580
45
Yang Luo, Yue Zhang, Di Wang, Di Shen, Yi-Qun Che. <p>Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study</p>Cancer Management and Research 2020; : 5323 doi: 10.2147/CMAR.S254580
46
Won Keun Si, Jung Wha Chung, Junhyeon Cho, Joo Yeong Baeg, Eun Sun Jang, Hyuk Yoon, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Soo Lim, Jin-Wook Kim, Motoyuki Otsuka. Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 DiabetesPLOS ONE 2016; 11(6): e0158066 doi: 10.1371/journal.pone.0158066
47
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessmentCancer Medicine 2019; 8(3): 1054 doi: 10.1002/cam4.1998
48
Makiko Taniai. Alcohol and hepatocarcinogenesisClinical and Molecular Hepatology 2020; 26(4): 736 doi: 10.3350/cmh.2020.0203
49
Xia Cui, Qingyan Li, Yukai He. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPLMolecular and Cellular Biochemistry 2017; 424(1-2): 195 doi: 10.1007/s11010-016-2855-2
50
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II RecommendationsJournal of Clinical and Experimental Hepatology 2020; 10(1): 43 doi: 10.1016/j.jceh.2019.09.007
51
Eric Siskind, Rolf N. Barth. Disease Recurrence After Liver Transplantation2016; : 105 doi: 10.1007/978-1-4939-2947-4_7
52
Varimadugu Aruna, A. Sneha, D. Sai Harshitha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 11 doi: 10.1016/B978-0-323-98806-3.00022-2
53
Gyongyi Szabo. Alcohol and CancerAdvances in Experimental Medicine and Biology 2018; 1032: 71 doi: 10.1007/978-3-319-98788-0_5
54
Hiroshi Matsushita, Akinobu Takaki. Alcohol and hepatocellular carcinomaBMJ Open Gastroenterology 2019; 6(1): e000260 doi: 10.1136/bmjgast-2018-000260
55
Subreen A. Khatib, Xin Wei Wang. Hepatobiliary Cancers: Translational Advances and Molecular MedicineAdvances in Cancer Research 2022; 156: 75 doi: 10.1016/bs.acr.2022.01.006
56
Paolo BORRO, Gianni TESTINO, Rinaldo PELLICANO, Fabio CAPUTO. Early detection of hepatocellular carcinoma in alcoholic liver diseasePanminerva Medica 2021; 63(4) doi: 10.23736/S0031-0808.19.03763-7
57
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular CarcinomaCells 2020; 9(2): 262 doi: 10.3390/cells9020262
58
Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Myoung Hun Chae, Chang Hwi Yoon, Jin-Woo Lee. Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experienceMedicine 2019; 98(47): e18020 doi: 10.1097/MD.0000000000018020
59
Wasit Wongtrakul, Sorachat Niltwat, Phunchai Charatcharoenwitthaya. The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.744713
60
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat DietsNutrients 2020; 12(4): 933 doi: 10.3390/nu12040933
61
Noor Atika Azit, Shahnorbanun Sahran, Leow Voon Meng, Manisekar Subramaniam, Suryati Mokhtar, Azmawati Mohammed Nawi, Yun-Wen Zheng. Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing countryPLOS ONE 2021; 16(12): e0260675 doi: 10.1371/journal.pone.0260675
62
Yvonne Huber, Franziska Bierling, Christian Labenz, Sandra Koch, Irene Schmidtmann, Roman Kloeckner, Sebastian Schotten, Tobias Huber, Hauke Lang, Marcus A. Woerns, Peter R. Galle, Arndt Weinmann, Julia Weinmann-Menke. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohortBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4677-y
63
Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert, Kenneth K. Tanabe. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational ChallengesJournal of Clinical Medicine 2020; 9(12): 3817 doi: 10.3390/jcm9123817
64
Yue Jia, Ping Ji, Samuel W. French. The Role of FAT10 in Alcoholic Hepatitis PathogenesisBiomedicines 2020; 8(7): 189 doi: 10.3390/biomedicines8070189
65
Kang Zheng, Francisco Cubero, Yulia Nevzorova. c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and DiseaseGenes 2017; 8(4): 123 doi: 10.3390/genes8040123
66
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor OnsetInternational Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
67
Sim Ming Ann, Glenn Kunnath Bonney, Ashokka Balakrishnan. Prehabilitation for Cancer Surgery2022; : 251 doi: 10.1007/978-981-16-6494-6_11
68
G. Testino, S. Leone. Chemoprevention of hepatocellular carcinoma in people affected by hepatitis C virus: what changes does the introduction of direct-acting antiviral agents make?Annals of Oncology 2016; 27(10): 1970 doi: 10.1093/annonc/mdw257
69
Yue Jia, Barbara French, Brittany Tillman, Samuel French. Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)Experimental and Molecular Pathology 2018; 105(1): 144 doi: 10.1016/j.yexmp.2018.07.005
70
Ron C. Gaba, Nasya Mendoza-Elias, Daniel P. Regan, Kelly D. Garcia, R. Peter Lokken, Regina M. Schwind, Michael Eichner, Faith M. Thomas, Lauretta A. Rund, Lawrence B. Schook, Kyle M. Schachtschneider. Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic PlatformJournal of Vascular and Interventional Radiology 2018; 29(8): 1194 doi: 10.1016/j.jvir.2018.03.007
71
Gianni Testino. Early detection of alcoholic liver diseaseScandinavian Journal of Gastroenterology 2016; 51(11): 1386 doi: 10.1080/00365521.2016.1199732
72
Mengna Wu, Huajie Miao, Rong Fu, Jie Zhang, Wenjie Zheng . Hepatic Stellate Cell: A Potential Target for Hepatocellular CarcinomaCurrent Molecular Pharmacology 2020; 13(4): 261 doi: 10.2174/1874467213666200224102820
73
Xiangye Liu, Tingting Li, Delong Kong, Hongjuan You, Fanyun Kong, Renxian Tang. Prognostic implications of alcohol dehydrogenases in hepatocellular carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07689-1
74
Nada Assi, Duncan C. Thomas, Michael Leitzmann, Magdalena Stepien, Véronique Chajès, Thierry Philip, Paolo Vineis, Christina Bamia, Marie-Christine Boutron-Ruault, Torkjel M. Sandanger, Amaia Molinuevo, Hendriek C. Boshuizen, Anneli Sundkvist, Tilman Kühn, Ruth C. Travis, Kim Overvad, Elio Riboli, Marc J. Gunter, Augustin Scalbert, Mazda Jenab, Pietro Ferrari, Vivian Viallon. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–Control Study in EPICCancer Epidemiology, Biomarkers & Prevention 2018; 27(5): 531 doi: 10.1158/1055-9965.EPI-17-0649